Listen "CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk."
Episode Synopsis
#DoctorPodcasts Episode 117:Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA authorization for the first A.I.-powered mammography tool - CLAIRITY BREAST - that predicts 5-year cancer risk. It will save many lives. For details go to Clairity.comWatch all 117 DoctorPodcasts || Cykiert Files video podcast interview episodes with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#BreastCancerPrediction#FDAuthorizedAI#ClairityBreast#ArtificialIntelligence#MammographyTool#CancerRiskPrediction#WomensHealth#MedicalInnovation#HealthcareTechnology#DoctorPodcasts#CykiertFiles#Episode117#ConnieLehman#JeffLuber#CLAIRITYInc#FiveYearRisk#EarlyDetection#PersonalizedMedicine#AIinHealthcare#BreastCancerAwareness#MedicalPodcasts#HealthcareExperts#InnovationInMedicine#TechInHealthcare#RiskAssessment#PreventiveHealthcare#DigitalHealth#MedicalResearch#ClinicalOncology#ASCO2025#FDAApproval#HealthTech#PrecisionMedicine#CancerPrevention#MammogramScreening#AIHealthcareSolutions#FutureOfMedicine#HealthInnovation#MedicalBreakthroughs#PatientCare#RobertCykiert#RobertCykiertMD
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.